This difference in treatment susceptibility could likely be attributable to nascent vessels being VEGF-dependent while mature tumor vessels have lost this dependence; with the basement membrane and pericyte coverage, they become resistant to VEGF inhibition [96]. This evidence concerns the gene VEGFA and neoplasm.